Michael S. Glickman

Michael S. Glickman is Professor of Medicine at Weill Cornell Medical College, specializing in mycobacterial genetics and cancer immunotherapy. His research spans Mycobacterium tuberculosis pathogenesis, DNA repair mechanisms, and microbiome interactions. A physician-scientist, he bridges clinical insights with fundamental research, focusing on antibiotic resistance, host-pathogen dynamics, and BCG-based cancer therapies.

• Education:
  • M.D., Columbia University College of Physicians and Surgeons (1993)
  • B.A., Dartmouth College (1989)

His work reveals critical roles for translesion polymerases, chaperone systems, and cyclopropane synthases in mycobacterial survival and drug resistance. Recombinant DNA repair pathways, including nonhomologous end joining, are central to his studies. Recent publications highlight microbial immunotherapy applications in cancer and metabolic regulation of virulence factors.

Notable grants include National Institute of Allergy & Infectious Diseases funding (2021–2026) for tuberculosis research. He collaborates with organizations like Vedanta Biosciences and serves on scientific advisory boards for Burroughs Wellcome Fund and the Institute for Research in Biomedicine Barcelona.